ADC at 3.0 T as a noninvasive biomarker for preoperative prediction of Ki67 expression in invasive ductal carcinoma of breast

Publication date: November–December 2018
Source:Clinical Imaging, Volume 52
Author(s): Lu Shen, Guoxing Zhou, Tong Tong, Fei Tang, Yi Lin, Jie Zhou, Yibin Wang, Genlin Zong, Lei Zhang
PurposeTo investigate the role of apparent diffusion coefficient (ADC) as an imaging biomarker for invasive ductal carcinoma (IDC) in the breast.MethodsSeventy-one patients undergoing 3.0 Tesla DWI were retrospectively enrolled. Correlations between the ADC values and prognostic factors were evaluated.ResultsMultivariate regression analyses showed that Ki67 expression and molecular subtype were independently associated with the ADC. Discriminant analysis excluded the ADC as a good biomarker for subtype, but the mean ADC significantly distinguished Ki67-positive (low ADC) from Ki67-negative (high ADC) lesions, as observed in the in ROC curves, with a diagnostic sensitivity of 1.00 and a cut-off value of 0.97 × 10⁻³ mm²/s.ConclusionThe ADC may be helpful for predicting Ki67 expression in IDC preoperatively.



http://ift.tt/2pBjCOw